膀胱原发混合性神经内分泌–非神经内分泌肿瘤一例
A Case of Primary Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms Tumor of the Bladder
摘要: 膀胱原发的混合性神经内分泌–非神经内分泌肿瘤(mixed neuroendocrine-non-neuroendocrine neoplasms, MiNENs)非常罕见，其神经内分泌多为小细胞神经内分泌癌(small cell neuroendocrine carcinoma, SCNEC)，而非神经内分泌成分常与尿路上皮癌有关。我们描述了一例膀胱的原发性MiNENs，由SCNEC和高级别浸润性尿路上皮癌组成，并探讨了其诊断、治疗和预后。
Abstract: Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) of bladder origin are very rare, and their neuroendocrine mostly small cell neuroendocrine carcinoma (SCNEC) and non-neuroendocrine components are often associated with uroepithelial carcinoma. We describe a case of primary MiNENs of the bladder, consisting of SCNEC and high-grade invasive uroepithelial carcinoma, and discuss its diagnosis, treatment, and prognosis.
文章引用：刘文瑶, 余肖. 膀胱原发混合性神经内分泌–非神经内分泌肿瘤一例[J]. 临床医学进展, 2025, 15(5): 941-945. https://doi.org/10.12677/acm.2025.1551453

参考文献

[1] Jubber, I., Ong, S., Bukavina, L., Black, P.C., Compérat, E., Kamat, A.M., et al. (2023) Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. European Urology, 84, 176-190. [Google Scholar] [CrossRef] [PubMed]
[2] Choong, N.W.W., Quevedo, J.F. and Kaur, J.S. (2005) Small Cell Carcinoma of the Urinary Bladder. Cancer, 103, 1172-1178. [Google Scholar] [CrossRef] [PubMed]
[3] Humphrey, P.A., Moch, H., Cubilla, A.L., Ulbright, T.M. and Reuter, V.E. (2016) The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours. European Urology, 70, 106-119. [Google Scholar] [CrossRef] [PubMed]
[4] Bazerbachi, F., Kermanshahi, T.R. and Monteiro, C. (2015) Early Precursor of Mixed Endocrine-Exocrine Tumors of the Gastrointestinal Tract: Histologic and Molecular Correlations. Ochsner Journal, 15, 97-101.
[5] La Rosa, S., Marando, A., Sessa, F. and Capella, C. (2012) Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. Cancers, 4, 11-30. [Google Scholar] [CrossRef] [PubMed]
[6] Garcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., et al. (2016) ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology, 103, 186-194. [Google Scholar] [CrossRef] [PubMed]
[7] Zhou, H.H., Liu, L.Y., Yu, G.H., et al. (2017) Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma. Anticancer Research, 37, 4529-4537.
[8] Koay, E.J., Teh, B.S., Paulino, A.C. and Butler, E.B. (2011) A Surveillance, Epidemiology, and End Results Analysis of Small Cell Carcinoma of the Bladder: Epidemiology, Prognostic Variables, and Treatment Trends. Cancer, 117, 5325-5333. [Google Scholar] [CrossRef] [PubMed]
[9] Shetty, D., Mashelkar, A., Sharan, A. and S., S. (2025) Small Cell Neuroendocrine Tumor of the Urinary Bladder: A Case Report. International Journal of Surgery Case Reports, 128, Article ID: 111045. [Google Scholar] [CrossRef] [PubMed]
[10] Akbulut, D. and Al-Ahmadie, H. (2024) Updates on Urinary Bladder Tumors with Neuroendocrine Features. Advances in Anatomic Pathology, 31, 169-177. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, I.E., Amin, A., Wang, L.J., Cheng, L. and Perrino, C.M. (2019) Insulinoma-Associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract. Applied Immunohistochemistry & Molecular Morphology, 28, 687-693. [Google Scholar] [CrossRef] [PubMed]
[12] Agoff, S.N., Lamps, L.W., Philip, A.T., Amin, M.B., Schmidt, R.A., True, L.D., et al. (2000) Thyroid Transcription Factor-1 Is Expressed in Extrapulmonary Small Cell Carcinomas but Not in Other Extrapulmonary Neuroendocrine Tumors. Modern Pathology, 13, 238-242. [Google Scholar] [CrossRef] [PubMed]
[13] Wee, P. and Wang, Z. (2017) Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers, 9, Article 52. [Google Scholar] [CrossRef] [PubMed]
[14] Pan, C., Yang, X.J., Lopez-Beltran, A., MacLennan, G.T., Eble, J.N., Koch, M.O., et al. (2005) C-Kit Expression in Small Cell Carcinoma of the Urinary Bladder: Prognostic and Therapeutic Implications. Modern Pathology, 18, 320-323. [Google Scholar] [CrossRef] [PubMed]
[15] Epstein, J.I. (2010) Diagnosis and Classification of Flat, Papillary, and Invasive Urothelial Carcinoma: The WHO/ISUP Consensus. International Journal of Surgical Pathology, 18, 106-111. [Google Scholar] [CrossRef] [PubMed]
[16] Ghervan, L., Zaharie, A., Ene, B. and Elec, F.I. (2017) Small-Cell Carcinoma of the Urinary Bladder: Where Do We Stand? Medicine and Pharmacy Reports, 90, 13-17. [Google Scholar] [CrossRef] [PubMed]
[17] National Comprehensive Cancer Network (2020) NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer.
[18] Myers, A.A., Fang, A.M., Moussa, M.J., Hwang, H., Wilson, N.R., Campbell, M.T., et al. (2024) Impact of Systemic Therapy on Clinical T1 Small-Cell Neuroendocrine Carcinoma of the Bladder. ESMO Open, 9, Article ID: 103964. [Google Scholar] [CrossRef] [PubMed]
[19] Lu, J., Zhou, J., Liu, Y., Li, Y., Tang, Y., Li, N., et al. (2024) Treatment and Survival of Non-Metastatic Small Cell Carcinoma of the Bladder from Multiple Centers in China. Scientific Reports, 14, Article No. 24652. [Google Scholar] [CrossRef] [PubMed]
[20] Liveringhouse, C., Sim, A.J., Zhang, J., Jain, R.K., Naidu, S.U., Linkowski, L., et al. (2024) A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder. Clinical Genitourinary Cancer, 22, Article ID: 102222. [Google Scholar] [CrossRef] [PubMed]

为你推荐